DOJ Announces Updated White-Collar Enforcement Priorities and Revised Policies - Earlier this week, the Criminal Division of the ...

Regeneron has agreed to buy 23andMe, the once buzzy genetic testing company, out of bankruptcy for $256 million under a court-supervised sale process. 23andMe declared bankruptcy in March and ...

As a result, personal bankruptcy inquiries are ticking up nationwide, surging to their highest level since 2020 during the first quarter of 2025. This spike is part of a larger trend of economic ...

Regeneron Pharmaceuticals agreed to purchase 23andMe for $256 million in a bankruptcy court auction, the company said Monday. The move allows 23andMe to continue to provide DNA testing services.

New research has found that nursing homes that filed for bankruptcy saw increases in negative resident outcomes and staff turnover. Investigators recommend transparency as a measure of getting a ...

Italian restaurant chain Bertucci’s is closing more locations after filing for bankruptcy again to mitigate losses. The Massachusetts-based business, which has locations along the East Coast and ...

The creditor who is owed more than $11 million from Deion Sanders’ son, Shilo, won a ruling from a federal bankruptcy judge Thursday that authorizes the creditor to obtain records from third ...

Matthew Herper covers medical innovation — both its promise and its perils. Regeneron Pharmaceuticals said Monday it had entered into an agreement to buy the consumer genetics firm 23andMe out ...

As families grapple with rising costs, experts emphasize the importance of exploring alternatives to bankruptcy for managing overwhelming debt. A recent report suggests that bankruptcy filings ...

Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal that provides the US biotech company with data on millions of clients.

The drugmaker Regeneron has emerged as the winner of a bankruptcy auction for 23andMe and its DNA database, with plans to incorporate its findings within its own research while continuing to offer ...